273 related articles for article (PubMed ID: 19520427)
1. Enhanced bone regeneration via multimodal actions of synthetic peptide SVVYGLR on osteoprogenitors and osteoclasts.
Egusa H; Kaneda Y; Akashi Y; Hamada Y; Matsumoto T; Saeki M; Thakor DK; Tabata Y; Matsuura N; Yatani H
Biomaterials; 2009 Sep; 30(27):4676-86. PubMed ID: 19520427
[TBL] [Abstract][Full Text] [Related]
2. The effect of the local delivery of alendronate on human adipose-derived stem cell-based bone regeneration.
Wang CZ; Chen SM; Chen CH; Wang CK; Wang GJ; Chang JK; Ho ML
Biomaterials; 2010 Nov; 31(33):8674-83. PubMed ID: 20719378
[TBL] [Abstract][Full Text] [Related]
3. Toward biomimetic materials in bone regeneration: functional behavior of mesenchymal stem cells on a broad spectrum of extracellular matrix components.
Ode A; Duda GN; Glaeser JD; Matziolis G; Frauenschuh S; Perka C; Wilson CJ; Kasper G
J Biomed Mater Res A; 2010 Dec; 95(4):1114-24. PubMed ID: 20878902
[TBL] [Abstract][Full Text] [Related]
4. Ectopic bone formation facilitated by human mesenchymal stem cells and osteogenic cytokines via nutrient vessel injection in a nude rat model.
Fukui M; Akita S; Akino K
Wound Repair Regen; 2005; 13(3):332-40. PubMed ID: 15953054
[TBL] [Abstract][Full Text] [Related]
5. Actions of fibroblast growth factor-8 in bone cells in vitro.
Lin JM; Callon KE; Lin JS; Watson M; Empson V; Tong PC; Grey A; Naot D; Green CR; Reid IR; Cornish J
Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E142-50. PubMed ID: 19383871
[TBL] [Abstract][Full Text] [Related]
6. Isoform-specific attachment of osteoprogenitors to laminins: mapping to the short arms of laminin-1.
Roche P; Rousselle P; Lissitzky JC; Delmas PD; Malaval L
Exp Cell Res; 1999 Aug; 250(2):465-74. PubMed ID: 10413600
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of amelogenin peptides on osteogenic differentiation in vitro: identification of possible new drugs for bone repair and regeneration.
Amin HD; Olsen I; Knowles JC; Donos N
Tissue Eng Part A; 2012 Jun; 18(11-12):1193-202. PubMed ID: 22320389
[TBL] [Abstract][Full Text] [Related]
8. Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo.
Cornish J; Callon KE; Bava U; Watson M; Xu X; Lin JM; Chan VA; Grey AB; Naot D; Buchanan CM; Cooper GJ; Reid IR
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E117-22. PubMed ID: 16912056
[TBL] [Abstract][Full Text] [Related]
9. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect.
Grellier M; Granja PL; Fricain JC; Bidarra SJ; Renard M; Bareille R; Bourget C; Amédée J; Barbosa MA
Biomaterials; 2009 Jul; 30(19):3271-8. PubMed ID: 19299013
[TBL] [Abstract][Full Text] [Related]
10. Direct inhibitory and indirect stimulatory effects of RAGE ligand S100 on sRANKL-induced osteoclastogenesis.
Yoshida T; Flegler A; Kozlov A; Stern PH
J Cell Biochem; 2009 Aug; 107(5):917-25. PubMed ID: 19415676
[TBL] [Abstract][Full Text] [Related]
11. The mineralization inducing peptide derived from dentin sialophosphoprotein for bone regeneration.
Choi YS; Lee JY; Suh JS; Lee G; Chung CP; Park YJ
J Biomed Mater Res A; 2013 Feb; 101(2):590-8. PubMed ID: 22961875
[TBL] [Abstract][Full Text] [Related]
12. Osteoclast size heterogeneity in rat long bones is associated with differences in adhesive ligand specificity.
Hu Y; Ek-Rylander B; Karlström E; Wendel M; Andersson G
Exp Cell Res; 2008 Feb; 314(3):638-50. PubMed ID: 18086469
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptide-coated bone mineral for enhanced osteoblastic activation in vitro and in vivo.
Lee JY; Choo JE; Park HJ; Park JB; Lee SC; Lee SJ; Park YJ; Chung CP
J Biomed Mater Res A; 2008 Dec; 87(3):688-97. PubMed ID: 18200552
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity.
Weinreb M; Shamir D; Machwate M; Rodan GA; Harada S; Keila S
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):81-90. PubMed ID: 16890416
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin controls differentiation of human mesenchymal stem cells and reverses osteoporosis.
Elabd C; Basillais A; Beaupied H; Breuil V; Wagner N; Scheideler M; Zaragosi LE; Massiéra F; Lemichez E; Trajanoski Z; Carle G; Euller-Ziegler L; Ailhaud G; Benhamou CL; Dani C; Amri EZ
Stem Cells; 2008 Sep; 26(9):2399-407. PubMed ID: 18583541
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of a tissue-engineered periosteum with acellular dermal matrix and cultured mesenchymal stem cells.
Schönmeyr B; Clavin N; Avraham T; Longo V; Mehrara BJ
Tissue Eng Part A; 2009 Jul; 15(7):1833-41. PubMed ID: 19125645
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Osteogenesis and Angiogenesis of Icariin in Local Controlled Release and Systemic Delivery for Calvarial Defect in Ovariectomized Rats.
Wu Y; Cao L; Xia L; Wu Q; Wang J; Wang X; Xu L; Zhou Y; Xu Y; Jiang X
Sci Rep; 2017 Jul; 7(1):5077. PubMed ID: 28698566
[TBL] [Abstract][Full Text] [Related]
18. Polydopamine-Laced Biomimetic Material Stimulation of Bone Marrow Derived Mesenchymal Stem Cells to Promote Osteogenic Effects.
Lee DJ; Lee YT; Zou R; Daniel R; Ko CC
Sci Rep; 2017 Oct; 7(1):12984. PubMed ID: 29021583
[TBL] [Abstract][Full Text] [Related]
19. High dose glucocorticoid hampers bone formation and resorption after bone marrow ablation in rat.
Kondo N; Tokunaga K; Ito T; Arai K; Amizuka N; Minqi L; Kitahara H; Ito M; Naito M; Shu-Ying J; Oda K; Murai T; Takano R; Ogose A; Endo N
Microsc Res Tech; 2006 Oct; 69(10):839-46. PubMed ID: 16972225
[TBL] [Abstract][Full Text] [Related]
20. Osteogenic potential of cultured human periosteum-derived cells - a pilot study of human cell transplantation into a rat calvarial defect model.
Sakata Y; Ueno T; Kagawa T; Kanou M; Fujii T; Yamachika E; Sugahara T
J Craniomaxillofac Surg; 2006 Dec; 34(8):461-5. PubMed ID: 17157522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
